Nicotine receptor agonist (NRA) angiogenic agent: Phase III testing update

Endovasc Ltd. Inc. (ENDV), Montgomery, Texas Product: Nicotine receptor agonist (NRA) angiogenic agent Business: Cardiovascular Therapeutic category: Receptor agonist Target: Nicotine receptor Descrip...